505 related articles for article (PubMed ID: 16493424)
1. Signalling pathways and molecular interactions of NOD1 and NOD2.
Strober W; Murray PJ; Kitani A; Watanabe T
Nat Rev Immunol; 2006 Jan; 6(1):9-20. PubMed ID: 16493424
[TBL] [Abstract][Full Text] [Related]
2. Nod1 signaling overcomes resistance of S. pneumoniae to opsonophagocytic killing.
Lysenko ES; Clarke TB; Shchepetov M; Ratner AJ; Roper DI; Dowson CG; Weiser JN
PLoS Pathog; 2007 Aug; 3(8):e118. PubMed ID: 17722978
[TBL] [Abstract][Full Text] [Related]
3. NOD1 and NOD2: signaling, host defense, and inflammatory disease.
Caruso R; Warner N; Inohara N; Núñez G
Immunity; 2014 Dec; 41(6):898-908. PubMed ID: 25526305
[TBL] [Abstract][Full Text] [Related]
4. Insights into the molecular basis of the NOD2 signalling pathway.
Boyle JP; Parkhouse R; Monie TP
Open Biol; 2014 Dec; 4(12):. PubMed ID: 25520185
[TBL] [Abstract][Full Text] [Related]
5. Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases.
Correa RG; Milutinovic S; Reed JC
Biosci Rep; 2012 Dec; 32(6):597-608. PubMed ID: 22908883
[TBL] [Abstract][Full Text] [Related]
6. The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling.
Irving AT; Mimuro H; Kufer TA; Lo C; Wheeler R; Turner LJ; Thomas BJ; Malosse C; Gantier MP; Casillas LN; Votta BJ; Bertin J; Boneca IG; Sasakawa C; Philpott DJ; Ferrero RL; Kaparakis-Liaskos M
Cell Host Microbe; 2014 May; 15(5):623-35. PubMed ID: 24746552
[TBL] [Abstract][Full Text] [Related]
7. Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.
Zhao Y; Alonso C; Ballester I; Song JH; Chang SY; Guleng B; Arihiro S; Murray PJ; Xavier R; Kobayashi KS; Reinecker HC
Inflamm Bowel Dis; 2012 Apr; 18(4):603-12. PubMed ID: 21887730
[TBL] [Abstract][Full Text] [Related]
8. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
Negroni A; Stronati L; Pierdomenico M; Tirindelli D; Di Nardo G; Mancini V; Maiella G; Cucchiara S
Inflamm Bowel Dis; 2009 Aug; 15(8):1145-54. PubMed ID: 19266573
[TBL] [Abstract][Full Text] [Related]
9. The role of Dectin-1 in the host defence against fungal infections.
Drummond RA; Brown GD
Curr Opin Microbiol; 2011 Aug; 14(4):392-9. PubMed ID: 21803640
[TBL] [Abstract][Full Text] [Related]
10. Macrophages: development and tissue specialization.
Varol C; Mildner A; Jung S
Annu Rev Immunol; 2015; 33():643-75. PubMed ID: 25861979
[TBL] [Abstract][Full Text] [Related]
11. The interferon response to intracellular DNA: why so many receptors?
Unterholzner L
Immunobiology; 2013 Nov; 218(11):1312-21. PubMed ID: 23962476
[TBL] [Abstract][Full Text] [Related]
12. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity.
Clarke TB; Davis KM; Lysenko ES; Zhou AY; Yu Y; Weiser JN
Nat Med; 2010 Feb; 16(2):228-31. PubMed ID: 20081863
[TBL] [Abstract][Full Text] [Related]
13. The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner.
Sorbara MT; Ellison LK; Ramjeet M; Travassos LH; Jones NL; Girardin SE; Philpott DJ
Immunity; 2013 Nov; 39(5):858-73. PubMed ID: 24238340
[TBL] [Abstract][Full Text] [Related]
14. NOD1 and NOD2 Signaling in Infection and Inflammation.
Moreira LO; Zamboni DS
Front Immunol; 2012; 3():328. PubMed ID: 23162548
[TBL] [Abstract][Full Text] [Related]
15. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry.
Travassos LH; Carneiro LA; Ramjeet M; Hussey S; Kim YG; Magalhães JG; Yuan L; Soares F; Chea E; Le Bourhis L; Boneca IG; Allaoui A; Jones NL; Nuñez G; Girardin SE; Philpott DJ
Nat Immunol; 2010 Jan; 11(1):55-62. PubMed ID: 19898471
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease: cause and immunobiology.
Baumgart DC; Carding SR
Lancet; 2007 May; 369(9573):1627-40. PubMed ID: 17499605
[TBL] [Abstract][Full Text] [Related]
17. NOD proteins: regulators of inflammation in health and disease.
Philpott DJ; Sorbara MT; Robertson SJ; Croitoru K; Girardin SE
Nat Rev Immunol; 2014 Jan; 14(1):9-23. PubMed ID: 24336102
[TBL] [Abstract][Full Text] [Related]
18. Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production.
Richards KH; Macdonald A
Microbes Infect; 2011 Apr; 13(4):291-302. PubMed ID: 21256242
[TBL] [Abstract][Full Text] [Related]
19. In vivo inhibition of RIPK2 kinase alleviates inflammatory disease.
Tigno-Aranjuez JT; Benderitter P; Rombouts F; Deroose F; Bai X; Mattioli B; Cominelli F; Pizarro TT; Hoflack J; Abbott DW
J Biol Chem; 2014 Oct; 289(43):29651-64. PubMed ID: 25213858
[TBL] [Abstract][Full Text] [Related]
20. Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.
Maisonneuve C; Bertholet S; Philpott DJ; De Gregorio E
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12294-9. PubMed ID: 25136133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
